SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
772Ablynx Announces Collaboration With Centocor Research and Development, Inc. Wednnigel bates-1/11/2006
771BioInvent Issued US Patent for n-CoDeR® Antibody Library [2006-01-11 11:44]Icebrg-1/11/2006
770Morphotek Announces IND Submission for MORAb-009, a Monoclonal Antibody for the nigel bates-1/9/2006
769CancerVax and Micromet Announce Merger Agreement Monday January 9, 3:01 am ET CIcebrg-1/9/2006
768Morphotek Announces Divestment of Cell Line Optimization and Cell Evolution Servnigel bates-1/5/2006
767Xencor and Roche Extend XmAb(TM) Antibody Therapeutics Collaboration MONROVIA, nigel bates-1/4/2006
766Wyeth Announces Strategic Collaboration with Trubion Pharmaceuticals <i>(Anigel bates-1/3/2006
765<i>Adaptive immune system in lampreys...</i> Cool. Interesting to nigel bates-12/31/2005
764Darpins molecularpartners.com molecularpartners.com Praveendr.praveen-12/30/2005
763MorphoSys Signs a Broad-Based Agreement for Use of Antibody Technologies With MeIcebrg-12/14/2005
762He was already mucking with MRC Collaborative Center, Celltech and Scotgen, but scaram(o)uche-12/13/2005
761Domantis Raises $29 Million in Series B Financing Sunday December 11, 7:00 am ETnigel bates-12/12/2005
760MedImmune Licenses Xencor's XmAb(TM) Technology to Create Antibody TherapeutIcebrg-12/8/2005
759Cancer breakthrough for drugs researcher A breakthrough in cancer treatment hasJohn McCarthy-12/8/2005
758Domantis' Dual Targeting Domain Antibodies Shown to Kill Multiple Myeloma Cenigel bates-12/7/2005
757Domantis is starting to look interesting (re tuck's last IP post, they recennigel bates-12/6/2005
756Domantis Enters Deal With BMS On Antibody Fragments By Nuala Moran BioWorld InIcebrg-12/6/2005
755Signals talks about the patent landscape in MabLand: signalsmag.com Cheers, Ttuck-12/5/2005
754Alder Biopharmaceuticals Inc. Forms Collaboration with Schering-Plough to IdentiIcebrg-12/2/2005
753Affitech and XOMA Sign Antibody Collaboration and Cross-License Agreement OSLOnigel bates-11/30/2005
752Faster Method To Create Antibodies For Disease Research 10/06/05 -- British sciIcebrg-10/12/2005
751MorphoSys Starts Multiple Antibody Programs with Schering AG Monday October 10, Icebrg-10/10/2005
750Miljenko The Medarex/Merck collaboration was for a bi-specific mAb called MDX-4Icebrg-9/30/2005
749You ought to tell Merck KGaA that they didn’t develop it. This is from their latDewDiligence_on_SI-9/30/2005
748How about "conflict of interest"? This candidate originated way back Miljenko Zuanic-9/29/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News